Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
365
Intervention sites will receive computer kiosk with study specific software to assist in reminding study participants to return for HPV vaccine series
Planned Parenthood of Arizona
Glendale, Arizona, United States
Planned Parenthood of Rocky Mountains
Arvada, Colorado, United States
Planned Parenthood of Rocky Mountains
Denver, Colorado, United States
Family Planning Clinic of the John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States
Planned Parenthood of Central North Carolina
Chapel Hill, North Carolina, United States
Planned Parenthood of North Carolina
Charlotte, North Carolina, United States
Planned Parenthood Association of Utah
Ogden, Utah, United States
Planned Parenthood Association of Utah
South Jordan, Utah, United States
Planned Parenthood of Greater Northwest
Seattle, Washington, United States
On-time Completion of the Human Papillomavirus Vaccine Series
Time frame: 32 weeks after receipt of initial vaccine
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.